|
|
This issue is co-sponsored by the Midwest and Pacific Lipid Associations
|
|
|
This issue is co-sponsored by the Northeast and Southeast Lipid Association
|
|
|
This issue is co-sponsored by the Northeast and Southeast Lipid Associations
|
|
|
This issue is sponsored by the Southwest Lipid Association
|
|
|
This issue is sponsored by the Midwest Lipid Association
|
|
|
This issue is sponsored by the Northeast Lipid Association
|
|
|
This issue is sponsored by the Southeast Lipid Association
|
|
|
This issue is sponsored by the Southwest Lipid Association.
|
|
|
This issue is sponsored by the Pacific Lipid Association.
Featuring: Clinical Trial Evidence for the Role of Reducing Inflammation for Cardiovascular Disease Prevention Identifying and Managing the Patient with High Inflammatory Burden Dietary Patterns and Systemic Inflammation: Examining the Connection
|
|
|
This issue sponsored by the Midwest Lipid Association
Featuring: "A National Lipid Association Best Practices Guide: PCSK9 Inhibitors"
|
.jpg)
.png)
(1).png)
